MedPath

Open-label, Multi-center Trial to Evaluate Safety and Efficacy of Cohesive Silicone Gel-Filled Breast Implants UNIGEL®

Not Applicable
Terminated
Conditions
Breast Augmentation
Interventions
Device: UNIGEL Silicone Gel-Filled Breast Implant
Registration Number
NCT02571751
Lead Sponsor
Sewoon Medical Co., Ltd
Brief Summary

Open-label, Multi-center, Clinical trial to Evaluate Safety and Efficacy of Cohesive Gel-Filled Breast Implants UNIGEL® Targeting of Women from 22 to 60 Aged with regard to Augmentation Mammaplasty for Purpose of Cosmetic Surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
69
Inclusion Criteria
  • Has given written informed consent to entry

  • Female, 22 years to 60 years

  • Breast augmentation(cosmetic surgery) is for following subjects

    • Who is not content with breast size and shape
    • Who has congenital asymmetrical deformity
  • subject who agree to MRI scan during the trial

  • subject who agree to visit to hospital according to schedule specified in the protocol during the entire period of the trial

Exclusion Criteria
  • Pregnant or lactating women and women of childbearing age
  • Subject who has operation history of breast augmentation or reconstruction
  • Subject who has fibrocystic Breast Disease coming up for precancerous lesion not accompanied with subcutaneous mastectomy
  • Subject who has breast cancer or prodromal phase and no proper treatment.
  • Subject who is diagnosed with Breast Imaging-Reporting and Data System(BI-RADS) category 3 under breast ultrasonography.
  • Subject who has uncontrolled active infectious disease or abscess
  • Autoimmune disease
  • Diabetes mellitus
  • Keloidosis
  • Subject who cannot take general anesthesia due to abnormal blood or ECG results.
  • Subject who is not appropriate for breast augmentation due to damaged tissue or blood vessel or ulcer
  • Subject who has metal materials in a body such as ventricular assist system or cerebral aneurysm clips, or has claustrophobia (not suitable for MRI SCAN)
  • Physically/mentally disabled subject that may disturb understanding and cooperation for the trial.
  • Any other conditions that may interfere with correct assessment of the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Breast AugmentationUNIGEL Silicone Gel-Filled Breast Implant-
Primary Outcome Measures
NameTimeMethod
a rate of capsular contracture of 10%2 years
a rate of rupture of 4%2 years
Secondary Outcome Measures
NameTimeMethod
Change in nipple sensitivity2 years
Change in chest, bust and under bust circumference2 years
SF-36(Short Form (36) Health Survey ), Evaluation of quality of life2 years
Kaplan-Meier Analysis of rupture or capsular contracture events2 years
a rate of adverse evnets2 years

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath